Regeneron
- All
- News
- Videos
-
5 Indian-Americans Among Finalists Of Prestigious High School Competition In US
Five Indian-American teenagers were among the 40 finalists of a prestigious science and maths competition for high school seniors in the US, who will compete for more than USD 1.8 million in awards.
-
German Lab Tests Find Certain Antibody Therapies Lose out Against Omicron
German researchers have found that COVID-19 therapies developed by Eli Lilly and Regeneron lose most of their effectiveness when exposed in laboratory tests to the Omicron variant, likely reducing treatment options if the new variant prevails.
-
Antibody Treatment May Be Less Effective On Omicron: Biotech Firm Regeneron
US biotech firm Regeneron said Tuesday that its synthetic antibody treatment for Covid-19 may be less effective against the new variant, and it plans to conduct tests to determine by how much.
-
World Health Organisation Backs Antibody Treatment For High-Risk Covid Patients
The World Health Organization (WHO) on Friday recommended the synthetic antibody treatment Regeneron for Covid-19, but only in patients with specific health profiles.
-
Cocktail Antibodies Injection Used First Time In Andhra Pradesh
A hospitalin Andhra Pradesh's Guntur district has administered cocktail antibodies injection 'Regeneron' to two patients. This is the first time the cocktail antibodies injection was used in Andhra Pradesh.
-
Regeneron Claims Its Covid-19 Antibody Therapy Demonstrated Promise in Hospitalised Patients
Casirivimab and imdevimab are not authorised for use in patients who are hospitalised or require oxygen therapy due to Covid-19, or for people currently using chronic oxygen therapy because of an underlying comorbidity
-
US Scientists Developing Nasal Spray To Prevent COVID-19
Scientists at the University of Pennsylvania and the biotech firm Regeneron are investigating whether technology developed for gene therapy can be used to make a nasal spray that will prevent infection with the new coronavirus.
-
Antibody Therapy Given To Trump For Covid Gets US Emergency Approval
A Covid-19 antibody therapy used to treat President Donald Trump was approved by the US drug regulator on Saturday for people who aren't yet hospitalized by the disease but are at high risk.
-
4 Indian-American Teens Awarded $25,000 Each For Environment Inventions
Four Indian American teenagers have been awarded $25,000 each for developing innovative approaches to address environmental issues.
-
Indian-American Teenager Indrani Das Wins Top Science Prize
Indian-American teenager, Indrani Das, won the top, $250,000 prize in the prestigious Regeneron Science Talent Search competition for her research on treating brain injuries and diseases.
-
Big Pharma Dominates Ranking Of Stocks With Best 5-year Returns
U.S. pharmaceutical companies dominated an annual global ranking of top 10 large-cap stocks with the best five-year returns, according to an analysis released on Tuesday by Boston Consulting Group.
-
Five Indian Firms Among Forbes' Most Innovative Companies
The other companies making up the top five on the list are Connecticut-based biotech firm Alexion Pharmaceuticals (2), British semi-conductor company ARM Holdings (3), fast moving consumer goods company Unilever Indonesia (4) and New York-based biopharmaceutical company Regeneron Pharmaceuticals (5).
-
5 Indian-Americans Among Finalists Of Prestigious High School Competition In US
Five Indian-American teenagers were among the 40 finalists of a prestigious science and maths competition for high school seniors in the US, who will compete for more than USD 1.8 million in awards.
-
German Lab Tests Find Certain Antibody Therapies Lose out Against Omicron
German researchers have found that COVID-19 therapies developed by Eli Lilly and Regeneron lose most of their effectiveness when exposed in laboratory tests to the Omicron variant, likely reducing treatment options if the new variant prevails.
-
Antibody Treatment May Be Less Effective On Omicron: Biotech Firm Regeneron
US biotech firm Regeneron said Tuesday that its synthetic antibody treatment for Covid-19 may be less effective against the new variant, and it plans to conduct tests to determine by how much.
-
World Health Organisation Backs Antibody Treatment For High-Risk Covid Patients
The World Health Organization (WHO) on Friday recommended the synthetic antibody treatment Regeneron for Covid-19, but only in patients with specific health profiles.
-
Cocktail Antibodies Injection Used First Time In Andhra Pradesh
A hospitalin Andhra Pradesh's Guntur district has administered cocktail antibodies injection 'Regeneron' to two patients. This is the first time the cocktail antibodies injection was used in Andhra Pradesh.
-
Regeneron Claims Its Covid-19 Antibody Therapy Demonstrated Promise in Hospitalised Patients
Casirivimab and imdevimab are not authorised for use in patients who are hospitalised or require oxygen therapy due to Covid-19, or for people currently using chronic oxygen therapy because of an underlying comorbidity
-
US Scientists Developing Nasal Spray To Prevent COVID-19
Scientists at the University of Pennsylvania and the biotech firm Regeneron are investigating whether technology developed for gene therapy can be used to make a nasal spray that will prevent infection with the new coronavirus.
-
Antibody Therapy Given To Trump For Covid Gets US Emergency Approval
A Covid-19 antibody therapy used to treat President Donald Trump was approved by the US drug regulator on Saturday for people who aren't yet hospitalized by the disease but are at high risk.
-
4 Indian-American Teens Awarded $25,000 Each For Environment Inventions
Four Indian American teenagers have been awarded $25,000 each for developing innovative approaches to address environmental issues.
-
Indian-American Teenager Indrani Das Wins Top Science Prize
Indian-American teenager, Indrani Das, won the top, $250,000 prize in the prestigious Regeneron Science Talent Search competition for her research on treating brain injuries and diseases.
-
Big Pharma Dominates Ranking Of Stocks With Best 5-year Returns
U.S. pharmaceutical companies dominated an annual global ranking of top 10 large-cap stocks with the best five-year returns, according to an analysis released on Tuesday by Boston Consulting Group.
-
Five Indian Firms Among Forbes' Most Innovative Companies
The other companies making up the top five on the list are Connecticut-based biotech firm Alexion Pharmaceuticals (2), British semi-conductor company ARM Holdings (3), fast moving consumer goods company Unilever Indonesia (4) and New York-based biopharmaceutical company Regeneron Pharmaceuticals (5).
